“A V/Q scan can be the first choice—but the CT angiogram is the classic choice—for diagnosing a pulmonary embolism,” noted H. Dirk Sostman, a professor of radiology and executive vice dean at Weill Cornell Medical College in New York City and chief academic officer at the Methodist Hospital in Houston, Texas. “A ‘very low probability’ V/Q lung scan—together with a ‘low probability’ objective clinical assessment—is as reliable as a CT angiogram and allows a doctor to evaluate whether a pulmonary embolism is present or not,” added Alexander Gottschalk, a professor of diagnostic radiology at Michigan State University in East Lansing.
A noninvasive V/Q scan involves two tests using radioactive material to measure breathing (ventilation) and circulation (perfusion) in all areas of the lungs, said Gottschalk, who has performed research with studies like the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) project for more than 30 years. V/Q scans reduce the radiation to the breast by about 70 times on average compared to higher-radiation procedures such as computed tomography pulmonary angiography (CTA), he explained.
“While CTA is the major test used widely to detect pulmonary embolisms, it is associated with higher radiation risk, especially for young women of reproductive age,” said Gottschalk. “The combination of a low probability V/Q scan and low probability clinical assessment is extremely effective,” said Sostman. “Our study is important for doctors—and their patients—since tests show that high radiation doses to the breast from CT, especially important in young women, may increase their risk of breast cancer,” he added.
A pulmonary embolism is a sudden blockage in a lung artery, usually occurring when a blood clot travels to the lung from a vein in the leg. This condition can cause permanent damage to a part of the lung. And, if a blood clot is large—or if they are numerous—a pulmonary embolism can cause death. According to statistics, at least 100,000 cases of pulmonary embolism take place each year in this country, and it is considered the third most common cause of death in hospitalized patients. A person’s risk at getting a pulmonary embolism doubles every 10 years after the age of 60.
In their study, Gottschalk and Sostman analyzed the prospectively gathered data from PIOPED II, a large-scale, multicenter trial. “Very Low Probability Interpretation of Ventilation Perfusion Lung Scans in Combination With Low Probability Objective Clinical Assessment Reliably Excludes Pulmonary Embolism: Data From PIOPED II” appears in the September issue of the Journal of Nuclear Medicine, which is published by SNM, the world’s largest molecular imaging and nuclear medicine society. Additional co-authors include Paul D. Stein, St. Joseph Mercy Oakland Hospital, Pontiac, Mich., Wayne State University, Detroit, Mich.; and Fadi Matta and Afzal Beemath, St. Joseph Mercy Oakland Hospital, Pontiac, Mich.
Media representatives: To obtain a copy of this article, please contact Maryann Verrillo by phone at (703) 652-6773 or send an e-mail to email@example.com. Current and past issues of the Journal of Nuclear Medicine can be found online at jnm.snmjournals.org. Print copies can be obtained by contacting the SNM Service Center, 1850 Samuel Morse Drive, Reston, VA 20190-5316; phone (800) 513-6853; e-mail firstname.lastname@example.org; fax (703) 708-9015. A subscription to the journal is an SNM member benefit.
About SNM—Advancing Molecular Imaging and Therapy
SNM is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of molecular and nuclear imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNM continues to provide essential resources for health care practitioners and patients; publish the most prominent peer-reviewed journal in the field (Journal of Nuclear Medicine); host the premier annual meeting for medical imaging; sponsor research grants, fellowships and awards; and train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances. SNM members have introduced—and continue to explore—biological and technological innovations in medicine that noninvasively investigate the molecular basis of diseases, benefiting countless generations of patients. SNM is based in Reston, Va.; additional information can be found online at http://www.snm.org.
Maryann Verrillo | EurekAlert!
3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg
Better equipped in the fight against lung cancer
16.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.
Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...
A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.
Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
18.05.2018 | Power and Electrical Engineering
18.05.2018 | Information Technology
18.05.2018 | Information Technology